Log in
Enquire now

List of Lpath patents

List of Lpath patents
List of Composecure patents
List of Sick AG patents
List of Mimi Hearing Technologies patents
List of funding rounds for COMPANYCAM, INC.
List of companies in Ally Bridge Group's investment portfolio
Patents where
Current Assignee
Name
is
‌
Lpath
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7829674 Compositions and methods for binding sphingosine-1-phosphate

Patent 7829674 was granted and assigned to Lpath on November, 2010 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
7829674
November 9, 2010
‌
US Patent 7956173 Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate

Patent 7956173 was granted and assigned to Lpath on June, 2011 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
7956173
June 7, 2011
‌
US Patent 8026342 Compositions and methods for binding sphingosine-1-phosphate

Patent 8026342 was granted and assigned to Lpath on September, 2011 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
8026342
September 27, 2011
‌
US Patent 8067549 Humanized antibodies and compositions for binding sphingosine-1-phosphate

Patent 8067549 was granted and assigned to Lpath on November, 2011 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
8067549
November 29, 2011
‌
US Patent 9274129 Methods and reagents for detecting bioactive lipids

Patent 9274129 was granted and assigned to Lpath on March, 2016 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
9274129
March 1, 2016
‌
US Patent 9274130 Prevention and treatment of pain using antibodies to lysophosphatidic acid

Patent 9274130 was granted and assigned to Lpath on March, 2016 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
9274130
March 1, 2016
‌
US Patent 8401799 Antibody design using anti-lipid antibody crystal structures

Patent 8401799 was granted and assigned to Lpath on March, 2013 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
8401799
March 19, 2013
‌
US Patent 8361465 Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents

Patent 8361465 was granted and assigned to Lpath on January, 2013 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
8361465
January 29, 2013
‌
US Patent 7862812 Methods for decreasing immune response and treating immune conditions

Patent 7862812 was granted and assigned to Lpath on January, 2011 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
7862812
January 4, 2011
‌
US Patent 8614103 Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions

Patent 8614103 was granted and assigned to Lpath on December, 2013 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
8614103
December 24, 2013
‌
US Patent 7901682 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation

Patent 7901682 was granted and assigned to Lpath on March, 2011 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
7901682
March 8, 2011
‌
US Patent 8871202 Prevention and treatment of pain using antibodies to sphingosine-1-phosphate

Patent 8871202 was granted and assigned to Lpath on October, 2014 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
8871202
October 28, 2014
‌
US Patent 9102718 Anti-S1P antibody treatment of patients with ocular disease

Patent 9102718 was granted and assigned to Lpath on August, 2015 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
9102718
August 11, 2015
‌
US Patent 9217749 Immune-derived moieties reactive against lysophosphatidic acid

Patent 9217749 was granted and assigned to Lpath on December, 2015 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
9217749
December 22, 2015
‌
US Patent 8796429 Bioactive lipid derivatives, and methods of making and using same

Patent 8796429 was granted and assigned to Lpath on August, 2014 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
8796429
August 5, 2014
‌
US Patent 9163091 Compositions and methods for binding lysophosphatidic acid

Patent 9163091 was granted and assigned to Lpath on October, 2015 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
9163091
October 20, 2015
‌
US Patent 7794713 Compositions and methods for the treatment and prevention of hyperproliferative diseases

Patent 7794713 was granted and assigned to Lpath on September, 2010 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
7794713
September 14, 2010
‌
US Patent 9181331 Pharmaceutical compositions for binding sphingosine-1-phosphate

Patent 9181331 was granted and assigned to Lpath on November, 2015 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
9181331
November 10, 2015
‌
US Patent 8444970 Compositions and methods for treating ocular diseases and conditions

Patent 8444970 was granted and assigned to Lpath on May, 2013 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
8444970
May 21, 2013
‌
US Patent 8158124 Compositions and methods for binding lysophosphatidic acid

Patent 8158124 was granted and assigned to Lpath on April, 2012 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
8158124
April 17, 2012
‌
US Patent 8222373 Humanized antibodies and compositions for binding sphingosine-1-phosphate

Patent 8222373 was granted and assigned to Lpath on July, 2012 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
8222373
July 17, 2012
‌
US Patent 8025877 Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphate

Patent 8025877 was granted and assigned to Lpath on September, 2011 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
8025877
September 27, 2011
‌
US Patent 8604172 Humanized antibody compositions and methods for binding lysophosphatidic acid

Patent 8604172 was granted and assigned to Lpath on December, 2013 by the United States Patent and Trademark Office.

‌
Lpath
United States Patent and Trademark Office
United States Patent and Trademark Office
8604172
December 10, 2013
23 results
0 selected
23 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us